Benjamin F. Edwards & Company, Inc. Abbott Laboratories Transaction History

Benjamin F. Edwards & Company, Inc.

$5.69 Billion
Q2 2024

A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 262,366 shares of ABT stock, worth $29.6 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

262,366

Previous 248,522 5.57%

Holding current value

$29.6 Million

Previous $28.2 Million 3.48%

% of portfolio

0.48%

Previous 0.51%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$100.73 - $112.44 $1.39 Million - $1.56 Million	13,844 Added 5.57%	262,366 $27.3 Million
Q1 2024 Apr 29, 2024	BUY	$109.52 - $120.96 $1.42 Million - $1.57 Million	12,971 Added 5.51%	248,522 $28.2 Million
Q4 2023 Feb 06, 2024	BUY	$90.19 - $110.4 $15.4 Million - $18.9 Million	171,077 Added 265.34%	235,551 $25.9 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $27,703 - $33,239	290 Added 0.45%	64,474 $6.24 Million
Q2 2023 Aug 15, 2023	BUY	$100.78 - $112.29 $1.32 Million - $1.47 Million	13,129 Added 25.72%	64,184 $7 Million
Q1 2023 Apr 27, 2023	BUY	$96.86 - $114.01 $13,269 - $15,619	137 Added 0.27%	51,055 $5.17 Million
Q4 2022 Feb 07, 2023	BUY	$95.06 - $111.52 $386,038 - $452,882	4,061 Added 8.67%	50,918 $5.59 Million
Q3 2022 Oct 28, 2022	BUY	$96.76 - $112.03 $40,058 - $46,380	414 Added 0.89%	46,857 $4.53 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $528,518 - $638,809	-5,178 Reduced 10.03%	46,443 $5.05 Million
Q1 2022 May 04, 2022	BUY	$114.02 - $139.04 $1.29 Million - $1.57 Million	11,297 Added 28.02%	51,621 $6.11 Million
Q4 2021 Feb 07, 2022	BUY	$115.53 - $141.46 $536,059 - $656,374	4,640 Added 13.0%	40,324 $5.68 Million
Q3 2021 Nov 02, 2021	SELL	$116.66 - $129.06 $132,409 - $146,483	-1,135 Reduced 3.08%	35,684 $4.22 Million
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $147,365 - $173,470	1,393 Added 3.93%	36,819 $4.27 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $164,021 - $193,242	1,507 Added 4.44%	35,426 $4.25 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $545,265 - $594,183	-5,193 Reduced 13.28%	33,919 $3.71 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $21,535 - $26,153	235 Added 0.6%	39,112 $4.26 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $52,603 - $67,326	-687 Reduced 1.74%	38,877 $3.56 Million
Q1 2020 May 07, 2020	SELL	$62.82 - $91.86 $45,356 - $66,322	-722 Reduced 1.79%	39,564 $3.12 Million
Q4 2019 Feb 06, 2020	BUY	$78.51 - $87.4 $82,278 - $91,595	1,048 Added 2.67%	40,286 $3.5 Million
Q3 2019 Nov 05, 2019	BUY	$81.84 - $88.74 $53,114 - $57,592	649 Added 1.68%	39,238 $3.28 Million
Q2 2019 Aug 08, 2019	BUY	$72.88 - $85.0 $271,040 - $316,115	3,719 Added 10.67%	38,589 $3.25 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $596,509 - $721,180	9,008 Added 34.83%	34,870 $2.79 Million
Q4 2018 Jan 31, 2019	BUY	$65.56 - $74.27 $168,948 - $191,393	2,577 Added 11.07%	25,862 $1.87 Million
Q3 2018 Oct 29, 2018	SELL	$60.81 - $73.36 $20,614 - $24,869	-339 Reduced 1.43%	23,285 $1.71 Million
Q2 2018 Jul 19, 2018	SELL	$57.57 - $63.54 $35,060 - $38,695	-609 Reduced 2.51%	23,624 $1.44 Million
Q1 2018 Apr 17, 2018	BUY	$56.27 - $63.62 $15,868 - $17,940	282 Added 1.18%	24,233 $1.45 Million
Q4 2017 Jan 17, 2018	BUY	$53.68 - $57.47 $50,137 - $53,676	934 Added 4.06%	23,951 $1.37 Million
Q3 2017 Oct 24, 2017	BUY	$48.06 - $53.64 $1.11 Million - $1.23 Million	23,017	23,017 $1.23 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.

Account

Benjamin F. Edwards & Company, Inc. Abbott Laboratories Transaction History